Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IM Ketamine vs Midazolam for Suicidal ER Patients

NCT04640636 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT04640636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04640636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IM Ketamine vs Midazolam for Suicidal ER Patients
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Suspended
Start date
February 9, 2021
Completion date
March 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, bipolar, depression, unipolar, suicidal ideation